GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
34 hedge funds and large institutions have $29.4M invested in Genocea Biosciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less capital invested
Capital invested by funds: $39.8M → $29.4M (-$10.5M)
Holders
34
Holding in Top 10
3
Calls
$3.13M
Puts
–
Top Buyers
| 1 | +$158K | |
| 2 | +$140K | |
| 3 | +$126K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$104K |
| 5 |
KCM
Kingdon Capital Management
New York
|
+$96.9K |
Top Sellers
| 1 | -$151K | |
| 2 | -$123K | |
| 3 | -$31.4K | |
| 4 |
D.E. Shaw & Co
New York
|
-$31K |
| 5 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
-$15K |